THE VOICE OF ONCOLOGY IN FLORIDA FLASCO is a member supported state society that focuses on providing education, advocacy, communication and general support of the Florida professionals who have chosen the challenging medical discipline of oncology. UPCOMING EVENTS CORPORATE MEMBERSHIP BENEFITS BENEFITS FOR ONCOLOGY PROFESSIONALS FLASCO

Latest News & Updates

Oppose the Most Favored Nation Interim Final Rule
January 8, 2021

Continue Reading »

Making you aware of a new molecular testing program in thyroid cancer
December 15, 2020

Continue Reading »

FDA approves pralsetinib for RET-altered thyroid cancers
December 8, 2020

Continue Reading »

FDA approves device for treatment of osteoid osteoma in the extremities
November 30, 2020

Continue Reading »

FDA Approves ORGOVYX (Relugolix) for the Treatment of Advanced Prostate Cancer
January 12, 2021

Continue Reading »

FDA Approves Margetuximab Plus Chemotherapy in HER2+ Metastatic Breast Cancer
December 17, 2020

Continue Reading »

FDA approves pralsetinib for RET-altered thyroid cancers
December 8, 2020

Continue Reading »

FDA grants accelerated approval to naxitamab for high-risk neuroblastoma in bone or bone marrow
November 30, 2020

Continue Reading »

Get More from FLASCO With Your Membership

The Corporate Membership Program allows FLASCO to expand our offerings to our membership. Every FLASCO meeting also provides the industry representative with opportunities to educate our members. When you send representatives to a FLASCO meeting, you are allowing them to share their knowledge, as well as receive the same knowledge as our members by participating within the educational sessions. This helps ensure that the hematology and oncology community at large are learning, sharing best practices, and finding solutions to problems together.

Corporate Members:

We're Here to Help Contact Us

Contact Us

Add your name, email & message below:

  • This field is for validation purposes and should be left unchanged.